HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nelsons Launches UK ‘Wellbeing Revolution’ With Rescue Extension

Executive Summary

Stress relief and sleep are the focus of Nelsons Rescue supplement extensions, which the company hopes will breathe new life into the 80-year-old brand and the UK's wellbeing category. The launches also see Nelsons enter the CBD category for the first time.

You may also be interested in...



‘Meaningful Revenues’ In 2023 Mark Strategic Milestone As Futura Looks To Future

Futura recorded its first notable revenues last year, generated by the launch of its Eroxon erectile dysfunction gel in the UK and Europe, marking the company's transition from an R&D startup to a consumer healthcare player in its own right. To mark the occasion, CEO James Barder outlines a new strategy, with a focus on innovation in sexual wellness, further global partnerships and sustained profitability. 

There’s ‘No Silver Bullet’ For Making Medicines Packaging Sustainable

There’s no simple answer to the question of how to make medicines packaging sustainable, says international recycling consultancy and Veolia Group subsidiary Circpack. “Manufacturers need to assess what works best for them, and recyclers will do the same,” Circpack analyst and circular packaging expert Filipe Vieira de Castro tells HBW Insight in this exclusive Q&A. “The best thing we can all do is put effort into finding common ground between systems, which comes down to better understanding the complexities between them.”

Haleon Real-World Study Shows Quality Of Life Improvement With Otrivine Use

Use of Haleon's Otrivin (marketed as Otrivine in some markets) is not just effective at treating nasal congestion during common cold but also demonstrates significant improvement in overall well-being and quality of life,” a recently published company-funded study shows.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151657

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel